Results 171 to 180 of about 9,480 (220)

Inhibition of acid ceramidase as a therapeutic strategy for Niemann-Pick C disease

Haynes I, Ward SE, Jones DH, Lloyd-Evans E, Waller-Evans H.   +4 more
europepmc   +1 more source

Staying sane in the membrane: Neutral sphingomyelinase 2 as a master regulator of plasma membrane ceramide. [PDF]

J Lipid Res
Quadri Z, Bieberich E.
europepmc   +1 more source

<i>Yarrowia lipolytica</i> as a promising cell factory for microbial production of value-added nutraceuticals. [PDF]

Front Bioeng Biotechnol
Lee S, Lee JH, Park HJ, Baek SH.
europepmc   +1 more source

Spinal muscular atrophy with progressive myoclonic epilepsy: A case report from China with new ASAH1 variants. [PDF]

Heliyon
Yin X, Shi J, Mei D, Guo J, Ma T, Gao Y, Wang L, Deng J.   +7 more
europepmc   +1 more source

Sphingolipid signaling in kidney diseases. [PDF]

Am J Physiol Renal Physiol
Li N, Li G.
europepmc   +1 more source

The Role of Sphingolipid Metabolism in Pregnancy-Associated Breast Cancer After Chemotherapy. [PDF]

Biomedicines
Blokhin V, Zavarykina T, Kotsuba V, Kapralova M, Gutner U, Shupik M, Kozyrko E, Luzina E, Lomskova P, Bajgazieva D, Khokhlova S, Alessenko A.   +11 more
europepmc   +1 more source

Targeting Sphingolipids in Breast Cancer: From Tumor Biology to Therapeutic Strategies. [PDF]

Oncol Res
Kim MH, Huh B, Park JW, Park WJ.
europepmc   +1 more source

Exploration of a Class of Aryl Imidazolyl Ureas As Potent Acid Ceramidase Inhibitors for the Treatment of Fibrotic Diseases. [PDF]

ACS Omega
Beresis R, Prathigudupu V, Cable C, Yu A, Adler M, Ramamoorthi R, Yeon SK, Gordan JD, Sharma S, DeGrado WF, Zaro B, Chen JY, Jo H.   +12 more
europepmc   +1 more source